Brand Stories May 16, 2022
Abbott Reaches Deal with FDA to Resume Infant Formula Production at Sturgis Plant
Abbott (NYSE: ABT) reached an agreement with the U.S. Food and Drug Administration (FDA) to resume production of infant formula…
Brand Stories May 16, 2022
Abbott (NYSE: ABT) reached an agreement with the U.S. Food and Drug Administration (FDA) to resume production of infant formula…
By Marivic Cabural Summers